Login / Signup

Reply to: Intravenous immunoglobulin (Gamunex® 10%) is licensed for the treatment of severe acute exacerbations of myasthenia gravis.

Fiammetta VanoliRenato Mantegazza
Published in: Expert opinion on pharmacotherapy (2023)
Keyphrases
  • myasthenia gravis
  • chronic obstructive pulmonary disease
  • cystic fibrosis
  • combination therapy
  • low dose